Recombinant plant-derived human IgE glycoproteomics

Journal of Proteomics

Volumn 161, Issue , 2017, Pages 81-87

  Montero Morales, Laura ^a   Maresch, Daniel ^a   Castilho, Alexandra ^a   Turupcu, Aysegül ^a   Ilieva, Kristina M ^b   Crescioli, Silvia ^b   Karagiannis, Sophia N ^b   Lupinek, Christian ^c   Oostenbrink, Chris ^a   Altmann, Friedrich ^a   Steinkellner, Herta ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b GUY S HOSPITAL   (United Kingdom)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Glycopeptide; Immunoglobulin E; Mass spectrometry; N glycosylation; Nicotiana benthamiana

Indexed keywords

CARBOHYDRATE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCAN; GLYCOPEPTIDE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1; PROTEINASE K; RECOMBINANT IMMUNOGLOBULIN E; RECOMBINANT PROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY; POLYSACCHARIDE;

ARTICLE; CONTROLLED STUDY; ELECTROSPRAY; GENE EXPRESSION SYSTEM; HEAVY CHAIN; HEK293 CELL LINE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MATHEMATICAL MODEL; NICOTIANA BENTHAMIANA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; TANDEM MASS SPECTROMETRY; WILD TYPE; BINDING SITE; CHEMISTRY; GENETICS; GLYCOSYLATION; PROCEDURES; PROTEOMICS; TOBACCO; TRANSGENIC PLANT;

ANTIBODIES, MONOCLONAL, HUMANIZED; BINDING SITES; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN E; PLANTS, GENETICALLY MODIFIED; POLYSACCHARIDES; PROTEOMICS; RECOMBINANT PROTEINS; TOBACCO;

EID: 85018472737     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2017.04.002     Document Type: Article

References (45)

1. [1] Gould, H.J., Sutton, B.J., IgE in allergy and asthma today. Nat. Rev. Immunol. 8:3 (2008), 205–217.
2. [2] Soussi Gounni, A., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, E., Capron, A., Kinet, J.-P., Capron, M., High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367:6459 (1994), 183–186.
3. [3] Karagiannis, S.N., Wang, Q., East, N., Burke, F., Riffard, S., Bracher, M.G., Thompson, R.G., Durham, S.R., Schwartz, L.B., Balkwill, F.R., Gould, H.J., Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur. J. Immunol. 33:4 (2003), 1030–1040.
4. [4] Karagiannis, P., Singer, J., Hunt, J., Gan, S.K., Rudman, S.M., Mechtcheriakova, D., Knittelfelder, R., Daniels, T.R., Hobson, P.S., Beavil, A.J., Spicer, J., Nestle, F.O., Penichet, M.L., Gould, H.J., Jensen-Jarolim, E., Karagiannis, S.N., Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. Cancer Immunol. Immunother. 58:6 (2009), 915–930.
5. [5] Singer, J., Jensen-Jarolim, E., IgE-based immunotherapy of cancer: challenges and chances. Allergy 69:2 (2014), 137–149.
6. [6] Arnold, J.N., Radcliffe, C.M., Wormald, M.R., Royle, L., Harvey, D.J., Crispin, M., Dwek, R.A., Sim, R.B., Rudd, P.M., The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J. Immunol. 173:11 (2004), 6831–6840.
7. [7] Plomp, R., Hensbergen, P.J., Rombouts, Y., Zauner, G., Dragan, I., Koeleman, C.A., Deelder, A.M., Wuhrer, M., Site-specific N-glycosylation analysis of human immunoglobulin E. J. Proteome Res. 13:2 (2014), 536–546.
8. [8] Robertson, M.W., Liu, F.T., Heterogeneous IgE glycoforms characterized by differential recognition of an endogenous lectin (IgE-binding protein). J. Immunol., 147, 1991, 7.
9. [9] Wu, G., Hitchen, P.G., Panico, M., North, S.J., Barbouche, M.R., Binet, D., Morris, H.R., Dell, A., Haslam, S.M., Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation. Glycoconj. J. 33:3 (2016), 447–456.
10. [10] Granato, D.A., Neeser, J.-R., Effect of trimming inhibitors on the secretion and biological activity of a murine IgE monoclonal antibody. Mol. Immunol. 24:8 (1987), 849–855.
11. [11] Gould, H.J., Sutton, B.J., Beavil, A.J., Beavil, R.L., McCloskey, N., Coker, H.A., Fear, D., Smurthwaite, L., The biology of IGE and the basis of allergic disease. Annu. Rev. Immunol. 21 (2003), 579–628.
12. [12] Kinet, J.P., The high-affinity IgE receptor (Fc[epsi]RI): from physiology to pathology. Annu. Rev. Immunol. 17 (1999), 931–972.
13. [13] Nettletone, M.Y., Kochan, J.P., Role of glycosylation sites in the IgE Fc molecule. Int. Arch. Allergy Immunol., 107(1–3), 1995, 2.
14. [14] Helm, B.A., Sayers, I., Padlan, E.A., McKendrick, J.E., Spivey, A.C., Structure/function studies on IgE as a basis for the development of rational IgE. Allergy 53 (1998), 77–82.
15. [15] Björklund, J., Karlsson, T., Magnusson, C., N-glycosylation influences epitope expression and receptor binding structures in human IgE. Mol. Immunol., 36(3), 1999.
16. [16] Hunt, J., Beavil, R.L., Calvert, R.A., Gould, H.J., Sutton, B.J., Beavil, A.J., Disulfide linkage controls the affinity and stoichiometry of IgE Fcepsilon3-4 binding to FcepsilonRI. J. Biol. Chem. 280:17 (2005), 16808–16814.
17. [17] Basu, M., Hakimi, J., Dharm, E., Kondas, J.A., Tsien, W.-H., Pilson, R.S., Lin, P., Gilfillan, A., Haring, P., Braswell, E.H., Nettletone, M.Y., Kochan, J.P., Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor. J. Biol. Chem., 1993.
18. [18] Young, R.J., Owens, R.J., Mackay, G.A., Chan, C.M.W., Shi, J., Hide, M., Francis, D.M., Henry, A.J., Sutton, B.J., Gould, H.J., Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosylation site mutants. Protein Eng. 8:2 (1995), 193–199.
19. [19] Shade, K.T., Platzer, B., Washburn, N., Mani, V., Bartsch, Y.C., Conroy, M., Pagan, J.D., Bosques, C., Mempel, T.R., Fiebiger, E., Anthony, R.M., A single glycan on IgE is indispensable for initiation of anaphylaxis. J. Exp. Med. 212:4 (2015), 457–467.
20. [20] Vercelli, D., The B-cell binding site on human immunoglobulin E. Nature 338 (1989), 649–651.
21. [21] Jacobs, P., Callewaert, N., N-glycosylation engineering of biopharmaceutical expression systems. Curr. Mol. Med. 9:7 (2009), 774–800.
22. [22] Yang, Z., Wang, S., Halim, A., Schulz, M.A., Frodin, M., Rahman, S.H., Vester-Christensen, M.B., Behrens, C., Kristensen, C., Vakhrushev, S.Y., Bennett, E.P., Wandall, H.H., Clausen, H., Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat. Biotechnol. 33:8 (2015), 842–844.
23. [23] Dekkers, G., Plomp, R., Koeleman, C.A., Visser, R., von Horsten, H.H., Sandig, V., Rispens, T., Wuhrer, M., Vidarsson, G., Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans. Sci. Rep., 6, 2016, 36964.
24. [24] Klimyuk, V., Pogue, G., Herz, S., Butler, J., Haydon, H., Production of recombinant antigens and antibodies in Nicotiana benthamiana using ‘magnifection’ technology: GMP-compliant facilities for small- and large-scale manufacturing. Palmer, K., Gleba, Y., (eds.) Plant Viral Vectors, 2014, Springer, Berlin, Heidelberg, 127–154.
25. [25] Strasser, R., Altmann, F., Steinkellner, H., Controlled glycosylation of plant-produced recombinant proteins. Curr. Opin. Biotechnol. 30 (2014), 95–100.
26. [26] Strasser, R., Stadlmann, J., Schahs, M., Stiegler, G., Quendler, H., Mach, L., Glossl, J., Weterings, K., Pabst, M., Steinkellner, H., Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 6:4 (2008), 392–402.
27. [27] Kallolimath, S., Steinkellner, H., Glycosylation of plant produced human antibodies. Human Antibodies, 23(3–4), 2015, 4.
28. [28] Dodev, T.S., Karagiannis, P., Gilbert, A.E., Josephs, D.H., Bowen, H., James, L.K., Bax, H.J., Beavil, R., Pang, M.O., Gould, H.J., Karagiannis, S.N., Beavil, A.J., A tool kit for rapid cloning and expression of recombinant antibodies. Sci. Rep., 4, 2014, 5885.
29. [29] Bantleon, F., Wolf, S., Seismann, H., Dam, S., Lorentzen, A., Miehe, M., Jabs, F., Jakob, T., Plum, M., Spillner, E., Human IgE is efficiently produced in glycosylated and biologically active form in lepidopteran cells. Mol. Immunol. 72 (2016), 49–56.
30. [30] Dicker, M., Tschofen, M., Maresch, D., Konig, J., Juarez, P., Orzaez, D., Altmann, F., Steinkellner, H., Strasser, R., Transient glyco-engineering to produce recombinant IgA1 with defined N- and O-glycans in plants. Front. Plant Sci., 7, 2016, 18.
31. [31] Marillonnet, S., Thoeringer, C., Kandzia, R., Klimyuk, V., Gleba, Y., Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol. 23:6 (2005), 718–723.
32. [32] Cho, H.-S., Mason, K., Ramyar, K.X., Stanley, A.M., Gabelli, S.B., Denney, D.W., Leahy, D.J., Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421:6924 (2003), 756–760.
33. [33] Castilho, A., Gruber, C., Thader, A., Oostenbrink, C., Pechlaner, M., Steinkellner, H., Altmann, F., Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation. MAbs 7:5 (2015), 863–870.
34. [34] Laffer, S., Lupinek, C., Rauter, I., Kneidinger, M., Drescher, A., Jordan, J.H., Krauth, M.T., Valent, P., Kricek, F., Spitzauer, S., Englund, H., Valenta, R., A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells. Allergy 63:6 (2008), 695–702.
35. [35] Wan, T., Beavil, R.L., Fabiane, S.M., Beavil, A.J., Sohi, M.K., Keown, M., Young, R.J., Henry, A.J., Owens, R.J., Gould, H.J., Sutton, B.J., The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat. Immunol. 3:7 (2002), 681–686.
36. [36] Drinkwater, N., Cossins, B.P., Keeble, A.H., Wright, M., Cain, K., Hailu, H., Oxbrow, A., Delgado, J., Shuttleworth, L.K., Kao, M.W., McDonnell, J.M., Beavil, A.J., Henry, A.J., Sutton, B.J., Human immunoglobulin E flexes between acutely bent and extended conformations. Nat. Struct. Mol. Biol. 21:4 (2014), 397–404.
37. [37] Jo, S., Im, W., Glycan fragment database: a database of PDB-based glycan 3D structures. Nucleic Acids Res. 41:Database issue (2013), D470–D474.
38. [38] Holdom, M.D., Davies, A.M., Nettleship, J.E., Bagby, S.C., Dhaliwal, B., Girardi, E., Hunt, J., Gould, H.J., Beavil, A.J., McDonnell, J.M., Owens, R.J., Sutton, B.J., Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI. Nat. Struct. Mol. Biol. 18:5 (2011), 571–576.
39. [39] Arnold, J.N., Wormald, M.R., Sim, R.B., Rudd, P.M., Dwek, R.A., The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25 (2007), 21–50.
40. [40] Loos, A., Gruber, C., Altmann, F., Mehofer, U., Hensel, F., Grandits, M., Oostenbrink, C., Stadlmayr, G., Furtmuller, P.G., Steinkellner, H., Expression and glycoengineering of functionally active heteromultimeric IgM in plants. Proc. Natl. Acad. Sci. U. S. A. 111:17 (2014), 6263–6268.
41. [41] Jefferis, R., Isotype and glycoform selection for antibody therapeutics. Arch. Biochem. Biophys. 526:2 (2012), 159–166.
42. [42] Nallet, S., Fornelli, L., Schmitt, S., Parra, J., Baldi, L., Tsybin, Y.O., Wurm, F.M., Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E cells. New Biotechnol. 29:4 (2012), 471–476.
43. [43] Mimura, Y., Kelly, R.M., Unwin, L., Albrecht, S., Jefferis, R., Goodall, M., Mizukami, Y., Mimura-Kimura, Y., Matsumoto, T., Ueoka, H., Rudd, P.M., Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines. J. Immunol. Methods 428 (2016), 30–36.
44. [44] Vamvaka, E., Twyman, R.M., Murad, A.M., Melnik, S., Teh, A.Y.-H., Arcalis, E., Altmann, F., Stoger, E., Rech, E., Ma, J.K.C., Christou, P., Capell, T., Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12. Plant Biotechnol. J. 14:1 (2016), 97–108.
45. [45] Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P., Kunert, R., Quendler, H., Pabst, M., Leonard, R., Altmann, F., Steinkellner, H., In planta protein sialylation through overexpression of the respective mammalian pathway. J. Biol. Chem. 285:21 (2010), 15923–15930.